Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > look at where they money from sale of voucher will go

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Oct 22, 2021 1:00pm

150 Views

Post# 34038016

RE:RE:look at where they money from sale of voucher will go

Wasn't long ago Stups was talking about market cap of $110M, sb the bottom and going higher with FDA approval. Facts.

The BOD has never "mandated to go towards R&D".

Can you provide the names of these scientists in the R&D? I doubt you can.

inventors wrote: The money is mandated to go towards R&D, and saleries are a big part of it.

One more month, anything can happen before, or after.

Perhaps the sp will bounce on trial rumours, and retreat on nerws.

The marketcap is close to $50 M....bottom should be realized here...?